HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED

Analyst Reco. Hansoh Pharmaceutical Group Company Limited

Stocks

3692

KYG549581067

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 09:08:21 12/06/2026 BST			5-day change	1st Jan Change
29.98 ^HKD	+2.60%		+0.60%	-16.91%

06-11	Weight-loss drug developers line up to tap lucrative market as competition heats up	RE
06-10	Hansoh Pharmaceutical's Application for HS-10568 Injection Accepted in China	MT

Analyst Reco.

03-31	Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$38 From HK$37.87, Keeps at Neutral	MT
02-16	Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$37.87 From HK$35.50, Keeps at Neutral	MT
23/10/25	Hansoh Pharmaceutical Group Company Limited Announces National Medical Products Administration Accepts New Drug Application of HS-10365 Capsules	CI
20/10/25	Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$35.50 From HK$35.47, Keeps at Neutral	MT
21/08/25	Jefferies Adjusts Hansoh Pharmaceutical Group's Price Target to HK$50 From HK$30, Keeps at Buy	MT
19/08/25	Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$35.47 From HK$31.82, Keeps at Neutral	MT
17/07/25	Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$31.82 From HK$25.64, Keeps at Neutral	MT
03/06/25	Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$25.64 From HK$19.86, Keeps at Neutral	MT
24/03/25	Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$19.86 From HK$18.36, Keeps at Neutral	MT
26/02/25	Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$18.36 From HK$17.95, Keeps at Neutral	MT
28/08/24	Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$17.95 From HK$17.23, Keeps at Neutral	MT
26/08/24	CMB International Capital Corp Starts Hansoh Pharmaceutical Group at Buy With HK$22.06 Price Target	MT
23/07/24	Nomura Adjusts Hansoh Pharmaceutical's Price Target to HK$17.23 From HK$15.03, Keeps at Neutral	MT
14/03/24	Nomura Downgrades Hansoh Pharmaceutical to Neutral From Buy, Adjusts Price Target to HK$15.03 From HK$13.01	MT
01/09/23	Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$13.01 From HK$19.49, Keeps at Buy	MT
10/03/23	Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$19.49 From HK$20.31, Keeps at Buy	MT
29/08/22	Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$20.31 From HK$20.88, Keeps at Buy	MT
30/03/22	Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$20.88 From HK$21.11, Keeps at Buy	MT

No results match your criteria

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Hansoh Pharmaceutical Group Company Limited : Regulator grants breakthrough-therapy status to lung cancer drug

Hansoh Pharmaceutical Group Company Limited : Regulator grants breakthrough-therapy status to lung cancer drug

December 03, 2024 at 05:31 pm

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
3692 Stock
News Hansoh Pharmaceutical Group Company Limited
Analyst Reco.

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrows Top Investments!

SEIZE THE OFFER!